Literature DB >> 11986425

Long-term follow-up of Hodgkin's disease trial.

George P Canellos, Donna Niedzwiecki.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11986425     DOI： 10.1056/NEJM200205023461821

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  23 in total

1.  Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy.

Authors:  Raynier Devillier; Diane Coso; Luca Castagna; Isabelle Brenot Rossi; Antonella Anastasia; Arturo Chiti; Vadim Ivanov; Jean Marc Schiano; Armando Santoro; Christian Chabannon; Monica Balzarotti; Didier Blaise; Reda Bouabdallah
Journal:  Haematologica       Date:  2012-01-22       Impact factor: 9.941

Review 2.  State of the art in the treatment of Hodgkin lymphoma.

Authors:  Peter Borchmann; Dennis A Eichenauer; Andreas Engert
Journal:  Nat Rev Clin Oncol       Date:  2012-06-12       Impact factor: 66.675

Review 3.  Gemcitabine and other new cytotoxic drugs: will any find their way into primary therapy?

Authors:  David W Dougherty; Jonathan W Friedberg
Journal:  Curr Hematol Malig Rep       Date:  2010-07       Impact factor: 3.952

4.  Factors affecting intrapatient liver and mediastinal blood pool ¹⁸F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin's lymphoma.

Authors:  Agostino Chiaravalloti; Roberta Danieli; Paolo Abbatiello; Barbara Di Pietro; Laura Travascio; Maria Cantonetti; Manlio Guazzaroni; Antonio Orlacchio; Giovanni Simonetti; Orazio Schillaci
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-22       Impact factor: 9.236

Review 5.  Advances in the treatment of Hodgkin lymphoma.

Authors:  Dennis A Eichenauer; Andreas Engert
Journal:  Int J Hematol       Date:  2012-10-11       Impact factor: 2.490

Review 6.  First-line treatment of Hodgkin's lymphoma.

Authors:  Beate Klimm; Andreas Engert; Volker Diehl
Journal:  Curr Hematol Malig Rep       Date:  2006-03       Impact factor: 3.952

Review 7.  Comparison of the efficiency of ABVD versus BEACOPP for Hodgkin lymphoma treatment: a meta-analysis.

Authors:  Yanxia Jiang; Yan Chen; Ruibin Huang; Guoan Chen
Journal:  Int J Hematol       Date:  2016-08-16       Impact factor: 2.490

8.  ABVD chemotherapy with reduced radiation therapy rates in children, adolescents and young adults with all stages of Hodgkin lymphoma.

Authors:  K C Marr; J M Connors; K J Savage; K J Goddard; R J Deyell
Journal:  Ann Oncol       Date:  2017-04-01       Impact factor: 32.976

Review 9.  The GHSG Approach to Treating Hodgkin's Lymphoma.

Authors:  Paul J Bröckelmann; Andreas Engert
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

10.  Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up.

Authors:  Ercole Brusamolino; Andrea Bacigalupo; Giovanni Barosi; Giampaolo Biti; Paolo G Gobbi; Alessandro Levis; Monia Marchetti; Armando Santoro; Pier Luigi Zinzani; Sante Tura
Journal:  Haematologica       Date:  2009-03-10       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.